GlobeNewswire

Thursday, January 29, 2026
Today's Paper
GlobeNewswire
The Manila Times
GlobeNewswire by Notified
no-image
Form 8.5 (EPT/RI)-NCC Group plc
January 29, 2026
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the "Code”)1.        KEY INFORMATION(a)        Name of exempt principal trader:Investec Bank plc(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offereeNCC Group plc(c)        Name of the party to the offer with which exempt principal trader is connected:Investec is Joint Broker to NCC
No Image
PRE ANNOUNCEMENT OF CERTIFICATE AUCTION TENDER
January 29, 2026
PRE ANNOUNCEMENT OF CERTIFICATE AUCTION TENDERMONETARY POLICY MEETING 2026-01-28AUCTION PERIODS COMMENCING: 2026-02-04: FIXED RATE 1.75 %(VALID UNTIL NEXT MONETARY POLICY MEETING)DEPOSIT RATE   1.65 %LENDING RATE   1.85 %
No Image
Study Results of Novel TYK2 Inhibitor Soficitinib in Patients with AD Published by JAMA Dermatology
January 29, 2026
BEIJING, Jan. 29, 2026 (GLOBE NEWSWIRE) -- JAMA Dermatology recently published the results of a Phase II study of novel TYK2 inhibitor soficitinib (ICP-332) in patients with moderate-to-severe atopic dermatitis (AD). The journal concluded that soficitinib demonstrated a favorable safety profile and encouraging efficacy, supporting further development for AD.This is a double-blind, placebo-controlled, phase 2 randomized clinical trial aiming to evaluate the safety and efficacy of soficitinib for moderate to severe AD. 75 participants were randomized 1:1:1 to receive soficitinib at 80 mg or 120
No Image
DPI and PODTECH Partner to Accelerate AI Infrastructure Deployment Globally
January 29, 2026
LONDON, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Datalec Precision Installations (DPI) and PODTECH today announced a global technology partnership to deliver pre-staged, deployment-ready AI infrastructure solutions as hyperscaler demand strains data centre capacity across Europe, Asia, and the Middle East. The partnership addresses critical bottlenecks in AI data centre commissioning, where vacancy rates in data centres have fallen to record lows of 6.5% in Europe and 5.9% in the U.K., driving unprecedented demand for turnkey infrastructure services.PODTECH brings extensive capability across
No Image
New Earth Resources Becomes Member of the Critical Minerals Institute
January 29, 2026
Vancouver, British Columbia, Jan. 29, 2026 (GLOBE NEWSWIRE) -- NEW EARTH RESOURCES CORP. (CSE: EATH) ("New Earth” or the "Company”) is pleased to announce its membership in the Critical Minerals Institute (CMI), a global organization advancing knowledge, collaboration, and opportunity in the critical minerals sector.The Critical Minerals Institute’s mission is to equip businesses, governments, and stakeholders with insights into the strategic importance, sustainability, and value of critical minerals-materials essential for technological innovation and industrial development. Through
No Image
21shares Launches Jito Staked SOL ETP (JSOL), Offering Enhanced Yield Exposure to Solana
January 29, 2026
The new ETP provides liquid access to JitoSOL, combining full Solana price exposure with a dual-source staking yieldZurich, 29 January 2026 - 21shares, one of the world’s largest issuers of cryptocurrency exchange-traded products (ETPs), today announced the launch of the 21shares Jito Staked SOL ETP (JSOL), providing investors with liquid, exchange-traded access to JitoSOL, the leading liquid staking asset within the Solana ecosystem.JSOL enables investors to access JitoSOL through their existing bank or broker, combining Solana market exposure with the enhanced rewards of liquid staking in
No Image
Acronis Expands #TeamUp Program in the Nordics with KuPS in Finland
January 29, 2026
Data Group Kuopio to deliver Acronis Cyber Protection to KuPS as part of the #TeamUp ProgramKOUPIO, Finland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, today announced the expansion of its #TeamUp Program in the Nordic region through a new partnership with Kuopion Palloseura (KuPS), one of Finland’s most respected football clubs, and Data Group Kuopio, a Managed Service Provider (MSP) which will serve as the Acronis #CyberFit Delivery Partner.Through the partnership, KuPS will use Acronis Cyber Protection solutions to secure its data,
No Image
Sampo Group's results for 2025 will be published on 5 February 2026
January 29, 2026
Sampo plc, press release, 29 January 2026 at 10:00 am EETSampo Group's results for 2025 will be published on 5 February 2026Sampo Group will publish the Financial Statement Release for 2025 on 5 February around 8:30 am Finnish time (6:30 am UK time). The report, the investor presentation, and a video review with Group CEO Morten Thorsrud will be available at www.sampo.com/result.Conference call5 February at 10:30 am Finnish time (8:30 am UK time)To ask questions, please join the teleconference by registering using the following link:
No Image
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
January 29, 2026
REYKJAVIK, ICELAND (January 29, 2026) - Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has reached a licensing and settlement agreement with Regeneron and Bayer, resolving all remaining patent disputes worldwide related to Alvotech’s biosimilar to Eylea® 2mg (aflibercept 40 mg/mL solution), which is approved for marketing in the European Economic Area, United Kingdom and Japan. In combination with the previously announced agreement which granted a Q4 2026 license
No Image
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
January 29, 2026
REYKJAVIK, Iceland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has reached a licensing and settlement agreement with Regeneron and Bayer, resolving all remaining patent disputes worldwide related to Alvotech’s biosimilar to Eylea® 2mg (aflibercept 40 mg/mL solution), which is approved for marketing in the European Economic Area, United Kingdom and Japan. In combination with the previously announced agreement which granted a Q4
No Image
Temenos Celebrates Collaboration and Innovation at Annual Partner Awards
January 29, 2026
IBM, Accenture and Capgemini among those recognized for their commitment to excellenceGRAND-LANCY, Switzerland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced the winners of its annual Partner awards, which recognize the excellence of Temenos Partners in driving innovation and customer success.William Moroney, Chief Revenue Officer, Temenos, commented: "Our Partners play a key role in helping Temenos transform banking and deepen our presence in key markets and larger banks, accelerating innovation and delivering better outcomes for
No Image
Kandi Technologies Enters into Strategic Cooperation with Qiji Energy, a Subsidiary of CATL
January 29, 2026
Strengthening Battery Swap Infrastructure Deployment to Accelerate Scaled Implementation of Heavy-truck Battery SwappingJinhua, China, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (the "Company” or "Kandi Technologies”) (NASDAQ GS: KNDI), a long renowned leader in all-electric personal transportation and utility vehicles, today announced that its wholly-owned subsidiary, China Battery Exchange (Zhejiang) Technology Co., Ltd. ("China Battery Exchange”), has entered into a three-year strategic cooperation agreement (the "Agreement”) with Times Qiji Green Energy
No Image
B2BINPAY Consolidates Major Releases V23, V24, and V25 for Enhanced Scalability
January 29, 2026
SAN SALVADOR, El Salvador, Jan. 29, 2026 (GLOBE NEWSWIRE) --B2BINPAY, a crypto payment processing for merchants, enterprises, and financial institutions, announces its consolidation of V23, V24, and V25 releases for a unified platform evolution. This strategic update delivers smart automation and frictionless onboarding, empowering clients to scale crypto payments and operations amid accelerating market demands for efficiency and reliability.At its core, the rollout transforms manual, siloed workflows into a cohesive infrastructure ready for 10x growth, streamlining every step from initial
No Image
Inside information: Suominen launches three-year profitability improvement program and introduces new operating model and leadership team
January 29, 2026
Kimmo Raunio photoKimmo Raunio photoMarika Vakiparta photoMarika Vakiparta photoSuominen Corporation's inside information on January 29, 2026, at 9:45 a.m. (EET)Suominen is launching a three-year program to improve the company’s profitability. The Full Potential Program targets 10% EBITDA by 2028. Suominen is also introducing a new functional operating model, with a dedicated focus on customers and factories, designed to strengthen expertise and effectiveness. Suominen is undertaking an ambitious transformation to unlock the company’s full potential. The first phase focuses on
No Image
Commencement of a new plan period in the share-based Long-Term Incentive Plan for management and key employees
January 29, 2026
Suominen Corporation's stock exchange release on January 29, 2026 at 9:35 a.m. (EET)                New Performance Period 2026-2028Based on the existing share-based Long Term Incentive Plan for management and key employees, communicated as a stock exchange release on February 6, 2024, the Board of Directors of Suominen Corporation has decided on the commencement of a new plan period covering the years 2026-2028.The purpose of the plan is to align the interests of the company’s shareholders and key employees to increase the company’s value in the long term, to commit
No Image
Suominen Corporation’s Financial Statements Release (unaudited) for January 1 - December 31, 2025: Unsatisfactory performance in a challenging environment
January 29, 2026
Suominen Corporation Financial Statements Release on January 29, 2026, at 9:30 a.m. (EET)Suominen Corporation’s Financial Statements Release (unaudited) for January 1 - December 31, 2025:Unsatisfactory performance in a challenging environmentKey figures 10-12/10-12/1-12/1-12/ 2025202420252024Net sales, EUR million95.3118.5412.4462.3Comparable EBITDA, EUR million1.94.212.617.0Comparable EBITDA, %2.03.63.13.7EBITDA, EUR million1.35.411.317.2EBITDA, %1.44.52.73.7Comparable operating profit / loss, EUR million-2.2-0.3-4.2-1.4Comparable operating profit / loss, %-2.4-0.2-1.0-0.3Operating profit
No Image
Enterome appoints leading hematologist and IFLI Executive Partner Mehrdad Mobasher, M.D., M.P.H., to its Board of Directors
January 29, 2026
Dr. Mobasher held several executive roles in industry, most recently CMO at BeiGeneIFLI contributed up to $9 million to Enterome’s private funding round in 2025Enterome has announced a series of encouraging clinical data for OncoMimics™ drug candidates in solid tumors and B-cell lymphomasParis, France - 29 JANUARY, 2025Enterome SA, a clinical-stage company pioneering OncoMimics™, a new class of off-the-shelf, multi-targeted in vivo immune therapies that induce a fast and potent expansion of memory T-cells to fight cancer, has appointed Mehrdad Mobasher, M.D., M.P.H., a hematologist
No Image
Hiab’s financial statements review 2025 to be published on Thursday, 12 February 2026
January 29, 2026
HIAB CORPORATION, PRESS RELEASE, 29 JANUARY 2026 AT 9:30 AM (EET)Hiab’s financial statements review 2025 to be published on Thursday, 12 February 2026Hiab Corporation will publish its financial statements review 2025 on Thursday, 12 February 2026 at approximately 8:00 a.m. EET. The report will be available at www.hiabgroup.com after publication.A live international telephone conference for analysts, investors and media will be arranged on the publishing day at 10:00 a.m. EET. The event will be held in English. The report will be presented by President and CEO Scott Phillips and CFO Mikko
No Image
Composition of Lassila & Tikanoja Plc’s Nomination Board
January 29, 2026
Lassila & Tikanoja PlcStock exchange release29 January 2026 at 9.25 AM EETComposition of Lassila & Tikanoja Plc’s Nomination BoardLassila & Tikanoja Plc’s three largest shareholders, who are determined on the basis of the shareholder register held by Euroclear as per 14 January 2026 and who are shareholders acting according to the principles otherwise mentioned in the Charter, are entitled to appoint their representatives to the company’s Nomination Board.According to the Charter of the Nomination Board, a group of shareholders may agree on the appointment of a joint representative to
No Image
HTX Announces Listing of USDe, Expanding Global Access to Ethena’s Delta-Neutral Synthetic Dollar
January 29, 2026
PANAMA CITY, Jan. 29, 2026 (GLOBE NEWSWIRE) -- HTX, a leading global cryptocurrency exchange, today announced the upcoming listing of USDe, the synthetic dollar developed by Ethena. This move further expands access to innovative, on-chain financial primitives for its global user base.The listing underscores HTX’s continued commitment to supporting next-generation digital assets and providing users with secure, forward-looking access to the rapidly evolving DeFi ecosystem."At HTX, we are constantly exploring models that push the boundaries of digital finance,” said Justin Sun, Global
icon-arrow 1 2 3 4 5 6 ... 8486 8487 icon-arrow
Page 1 of 8487

Get the latest news
delivered to your inbox
Sign up for The Manila Times newsletters
By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.




TRY THE MANILA TIMES PREMIUM
FREE FOR 14 DAYS
SUBSCRIBE NOW
ALREADY A SUBSCRIBER?
LOGIN HERE
DOWNLOAD THE DIGITAL EDITION APP